EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN) fair value: what the stock is really worth

As of Oct 1, 2026: fair value of PROTEAN EGOV TECHNOLOGIES LTD ₹431, price ₹640, upside -32.7%, quality 63 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Technology · IN

PE Broad data Sep 27, 2026

PROTEAN EGOV TECHNOLOGIES LTD

PROTEAN · NSE

Overvalued / MonitorQuality is not strong enough to offset the price risk.

!Fair value ₹430.69 · Overvalued (−32.7%)
✓Quality 63/100
!Mixed Growth (revenue 3y +10.9 %/yr)
✓Solidly profitable · 10.1% net margin (TTM)
✓generates free cash flow
✓1.6% dividend yield · Well covered
!Trails peers (5/13)
!Narrow moat 44/100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

₹1,454 ₹446.40 Fair Value ₹430.69 Feb 2025 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.

How to read this chart

20‑month range ₹446.40 – ₹1,454 · fair‑value band ₹289.89 – ₹532.27 · the ₹639.75 price screens above the ₹430.69 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 27, 2026.

Follow PROTEAN EGOV TECHNOLOGIES in your weekly email

Every Wednesday you see whether PROTEAN EGOV TECHNOLOGIES is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Protean eGov Technologies Limited, together with its subsidiaries, provides information technology (IT) enabled e-governance services in India.

Show more

Protean eGov Technologies Limited, together with its subsidiaries, provides information technology (IT) enabled e-governance services in India. The company conceptualizes, develops, and executes critical and population scale greenfield technology solutions; and offers citizen services, system integration, business process re-engineering, data center co-location, and IT consulting services for individuals, corporates, and the government. It also operates as a central recordkeeping agency and a tax information network; and processes the applications for allotment of permanent account numbers (PAN). In addition, the company offers open digital ecosystems for mobility, e-commerce, health, agriculture, education, and skilling; and Vidyasaarathi and VidyaLakshmi, which are online platforms for education loans. Further, the company provides online PAN verification services; e-KYC to manage authentication of digital IDs; eSign to facilitate digital signatures; eSignPro, which offers e-stamps and digital stamp solutions; Aadhaar authentication for digital identity; GST services; FIP and FIU technology service provider services; Data Stack, a data analytics solution; Rise with Protean, a multisectoral shop for APIs, micro services, and user journeys; ProteanX, a suite of products used to create, issue, store, and manage verifiable credentials; and Protean CKYC solution. Additionally, it offers cloud services, such as desktop as a service, storage as a service, virtual office, infrastructure as a service, managed service, and edge compute with 5G private network; and information security consulting services, including information security architecture, data privacy practice, and cyber security consulting and advisory services. The company was formerly known as NSDL e-Governance Infrastructure Limited and changed its name to Protean eGov Technologies Limited in October 2021. Protean eGov Technologies Limited was incorporated in 1995 and is headquartered in Mumbai, India.

Stock analysis

PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN) currently trades at ₹639.75, while our model-based Fair Value estimate is ₹430.69, 32.7% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of ₹587.78 per share, and 3 of the 26 models we run sit above the ₹639.75 price.

Bear case: the Dividend Discount group reads lowest at ₹110.38, and 23 of the 26 models stay below the price. Evidence for this calculation is high.

Scenario range: ₹289.89 (bear) to ₹532.27 (bull), the price of ₹639.75 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 63/100 (solid quality), in the Technology sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

PROTEAN EGOV TECHNOLOGIES LTD reported revenue of ₹10.0B in FY2026 versus ₹6.9B in FY2022, a compound +9.7%/yr. Reported net income was ₹1.0B in FY2026, compounding −8.6%/yr from FY2022.

Key figures

Market cap ₹26.1B (≈ $271M) · P/E ratio 25.9 · P/S ratio 2.61 · EPS (TTM) ₹24.72 · Dividend yield 1.6% · Net margin 10.1% · Return on equity 9.7% · Return on assets (EBIT) 6.8%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).

What moves the price

The share trades about 29% below its 52-week high and 43% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Technology peers we cover trades at 44% fair-value upside, at −33%, PROTEAN screens richer than that median.

Fair Value models

Bear ₹289.89 Fair Value ₹430.69 Bull ₹532.27
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then (₹7.46 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF ₹272.86 ₹420.34 ₹639.79 74
Residual Income ₹206.40 ₹218.07 ₹242.53 73
Growth DCF ₹267.31 ₹391.70 ₹562.06 72
All 26 models by family
DCF Models
FCF DCF ₹272.86 ₹420.34 ₹639.79 74
Owner Earnings ₹304.40 ₹472.39 ₹722.35 70
5Y Revenue Exit ₹226.72 ₹344.89 ₹503.43 67
5Y EBITDA Exit ₹346.48 ₹597.44 ₹917.92 68
5Y P/E Exit ₹420.96 ₹754.50 ₹1,146 64
10Y Revenue Exit ₹238.30 ₹347.95 ₹513.30 61
10Y EBITDA Exit ₹310.93 ₹508.23 ₹816.39 62
10Y P/E Exit ₹353.62 ₹607.91 ₹982.85 57
Earnings-Based
Graham-Dodd ₹168.39 ₹848.90 ₹1,172 61
Lynch FV ₹230.20 ₹328.85 ₹427.51 58
PEG = 1.0 ₹230.20 ₹328.85 ₹427.51 55
EPV ₹114.71 ₹122.96 ₹129.66 70
Dividend Discount
Gordon GGM ₹69.48 ₹116.38 ₹151.05 65
DDM Multi-Stage ₹69.48 ₹110.38 ₹125.20 65
Multiples
P/E Multiple ₹520.02 ₹693.36 ₹866.70 63
P/S Multiple ₹315.73 ₹420.97 ₹526.21 58
P/B Multiple ₹315.73 ₹420.97 ₹526.21 55
EV/EBIT ₹350.65 ₹452.23 ₹553.81 63
EV/EBITDA ₹429.84 ₹557.81 ₹685.78 64
EV/Revenue ₹199.98 ₹266.00 ₹332.03 52
Asset-Based
NCAV (Graham) ₹132.61 ₹177.70 ₹265.22 51
Growth DCF
Growth DCF ₹267.31 ₹391.70 ₹562.06 72
Rev-Margin DCF ₹226.72 ₹343.49 ₹498.40 67
Economic Profit
Residual Income ₹206.40 ₹218.07 ₹242.53 73
ROIC Compounder ₹114.71 ₹122.96 ₹129.66 67
Growth Earnings
Growth-Adj P/E ₹411.45 ₹587.78 ₹764.12 65

Open the full fair value analysis →

Notify me when PROTEAN reaches fair value

Put PROTEAN on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 63/100

Of which business quality 63 · Market factors (momentum, volatility) 45

Profitability 42
Margins and returns on capital today
Quality Growth 50
Are margins and returns improving?
Cashflow 53
Earnings quality: real cash, not paper profit
Fin. Strength 88
Balance sheet, leverage, solvency risk
Investment 66
Disciplined investing over empire-building
Low Volatility 66
Calm price path (market factor)
Momentum 44
Price trend over the last 3–12 months (market factor)
52W Momentum 23
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 88/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+18.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.9%
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−5.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year−7.0%
Dividend (yield on the price)1.6%
Profit margin 2022 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.16% → 7%

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+23.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+8.4%
Yearly sales growth analysts expect, extended to five years.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about +18.4% a year for the price and +4.1% for the forecasts.
Forecast 2027 (sales)+9.5%
Forecast 2028 (sales)+9.5%
Projected 2029 (sales)+8.6%
Projected 2030 (sales)+7.7%
Projected 2031 (sales)+6.7%

PROTEAN screens overvalued: fair value 33% below the price. Compare with International Business Machines Corporation →

Compare PROTEAN EGOV TECHNOLOGIES LTD with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Information Technology Services · 462 stocks

Beats the industry median on 5/13 measures
Overall it trails its industry peers.
Valuation
Quality Score 63 · Above median
Fair Value upside −32.7% · Below median
Profitability
Return on equity (TTM) 9.7% · Above median
Return on assets 3.1% · Below median
Net margin (TTM) 10.1% · Top 25%
Operating margin (TTM) 7.8% · Above median
Growth and dividend
Revenue growth 38.4% · Top 25%
Dividend yield (TTM) 1.6% · Below median

Valuation Multiplesvs Information Technology Services median · lower = cheaper

P/E (TTM) 25.9× · Pricier than median
P/B 2.42× · Pricier than median
P/S (TTM) 2.61× · Priciest 25%
P/FCF 28.3× · Priciest 25%
EV/EBITDA 20.9× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 43
FUTURE (revenue growth)100 · sector 29
PAST (return on equity)39 · sector 37
HEALTH (low debt)0 · sector 97
DIVIDEND (yield)31 · sector 41

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Information Technology Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
International Business Machines Corporation IBM $219.93 $186.56 −15%
Accenture plc ACN $183.37 $305.06 +66%
Tata Consultancy Services Limited TCS ₹2,082 ₹2,993 +44%
Infosys Limited INFY ₹994.10 ₹1,691 +70%
HCL Technologies Limited HCLTECH ₹1,258 ₹1,926 +53%
Cognizant Technology Solutions Corporation CTSH $56.84 $138.62 +144%
Amadeus IT Group AMS €53.48 €65.98 +23%
Broadridge Financial Solutions, Inc BR $163.77 $159.88 −2%
Fidelity National Information Services, Inc FIS $33.35 $32.72 −2%
CDW Corporation CDW $129.71 $165.54 +28%

Explore undervalued stocks

More undervalued Technology stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "PROTEAN EGOV TECHNOLOGIES LTD Fair Value". https://www.fairvalue-calculator.com/stock/PROTEAN

Frequently asked questions

Is PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of ₹430.69 versus a price of ₹639.75, about −33% upside (overvalued).
What is the fair value of PROTEAN?
Our model-based fair value for PROTEAN EGOV TECHNOLOGIES LTD is ₹430.69 (as of Sep 27, 2026), built from audited fundamentals. The current price: ₹639.75.
What is the quality score of PROTEAN?
PROTEAN EGOV TECHNOLOGIES LTD has a Quality Score of 63/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN)?
Our model-based price target is the fair value of ₹430.69 (as of Sep 27, 2026) from 26 valuation models. Cautious scenario ₹289.89, optimistic scenario ₹532.27. It is a calculation from audited fundamentals, not an analyst target.
What is the PROTEAN EGOV TECHNOLOGIES LTD stock forecast for 2026?
Our models put fair value at ₹430.69, about −33% upside versus a price of ₹639.75 (overvalued). Cautious scenario ₹289.89, optimistic scenario ₹532.27. The calculation is refreshed regularly with new filings.
What is the revenue of PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN)?
PROTEAN EGOV TECHNOLOGIES LTD reported trailing-twelve-month revenue of about ₹10.0B (latest available figure, as of Sep 27, 2026).
Does PROTEAN EGOV TECHNOLOGIES LTD pay a dividend?
PROTEAN EGOV TECHNOLOGIES LTD currently shows a dividend yield of about 1.56% relative to its recent price (as of Sep 27, 2026).
What growth is priced into PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN)?
For today's price to be fair in a discounted-cash-flow model, PROTEAN EGOV TECHNOLOGIES LTD would have to grow free cash flow by +23.3 % per year for five years (discount rate 13.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 4 years revenue grew +9.7 % per year. As of Sep 27, 2026.
What discount rate (WACC) does the fair value of PROTEAN use?
Our models discount PROTEAN EGOV TECHNOLOGIES LTD at 13.9 %: a base by market capitalisation (micro), damped by beta 0.34, country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For PROTEAN EGOV TECHNOLOGIES LTD that is +23.3 % per year a year over ten years, using the same discount rate (13.9 %) and the same formula as our fair value.
How much growth has PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN) delivered so far?
Over the past 4 years revenue at PROTEAN EGOV TECHNOLOGIES LTD grew +9.7 % a year. The price currently implies +23.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN) growing?
The median revenue growth in the sector is +12.9 % a year. That is the yardstick for the growth priced into PROTEAN EGOV TECHNOLOGIES LTD (+23.3 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN)?
The free-cash-flow yield on the price is 3.54 %: that much free cash flow PROTEAN EGOV TECHNOLOGIES LTD produces per unit of market value. When it exceeds the discount rate of our models (13.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For PROTEAN EGOV TECHNOLOGIES LTD it is ₹430.69 per share (as of Sep 27, 2026), against a price of ₹639.75. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is PROTEAN EGOV TECHNOLOGIES LTD stock overvalued or undervalued in 2026?
As of Sep 27, 2026, PROTEAN trades above its calculated fair value: price ₹639.75, fair value ₹430.69, a gap of about −33% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of PROTEAN?
No. The price is what the market pays today (₹639.75); the fair value is what the company's own numbers justify (₹430.69). For PROTEAN EGOV TECHNOLOGIES LTD the two are ₹209.06 per share apart. That gap is exactly why we show both numbers side by side.
How much is PROTEAN EGOV TECHNOLOGIES LTD worth?
The market values PROTEAN EGOV TECHNOLOGIES LTD at about ₹26.1B (market capitalisation, as of Sep 27, 2026). Per share that is ₹639.75; our models calculate a fair value of ₹430.69 per share.
What do the bullish and bearish scenarios say about PROTEAN?
Our models span a range for PROTEAN EGOV TECHNOLOGIES LTD: cautious scenario ₹289.89, base ₹430.69, optimistic ₹532.27 per share (as of Sep 27, 2026, price ₹639.75). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of PROTEAN?
PROTEAN EGOV TECHNOLOGIES LTD trades at a price-to-earnings ratio of 25.9 (as of Sep 27, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹430.69 is built from several models across several years. Other multiples: P/B 2.4, P/S 2.6, EV/EBITDA 20.9.
How solid is the balance sheet of PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN)?
Balance-sheet figures for PROTEAN EGOV TECHNOLOGIES LTD (as of Sep 27, 2026): return on equity 9.7%. They feed the Quality Score of 63/100, which measures business quality independently of the share price.
How far is PROTEAN from its 52-week high?
PROTEAN EGOV TECHNOLOGIES LTD trades at ₹639.75, about 29% below its 52-week high of ₹896.60 and 43% above the low of ₹446.40 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹430.69 is for.
Which stocks are comparable to PROTEAN EGOV TECHNOLOGIES LTD?
From the same area (Technology) we also value International Business Machines Corporation, Accenture plc, Tata Consultancy Services Limited, Infosys Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is PROTEAN EGOV TECHNOLOGIES LTD stock attractive at the current price?
The data as of Sep 27, 2026: price ₹639.75, calculated fair value ₹430.69 (−33%), Quality Score 63/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of PROTEAN calculated?
We run PROTEAN EGOV TECHNOLOGIES LTD through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹430.69, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. PROTEAN EGOV TECHNOLOGIES LTD itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN)?
The closing price on Oct 1, 2026 was ₹639.75. Our model-based fair value is ₹430.69, about −33% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with PROTEAN EGOV TECHNOLOGIES LTD right now?
The price sits above even our optimistic bull case (₹532.27). The favourable scenario is already priced in. Solid but not exceptional quality (63/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (₹289.89 to ₹532.27) leaves room in how you read the outcome.

Key figures of PROTEAN EGOV TECHNOLOGIES LTD

How large is the market capitalisation of PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN)?
The market capitalisation of PROTEAN EGOV TECHNOLOGIES LTD is ₹26.1B (≈ $271M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN)?
The price-to-sales ratio of PROTEAN EGOV TECHNOLOGIES LTD is 2.61 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN)?
Earnings per share at PROTEAN EGOV TECHNOLOGIES LTD are ₹24.72 (price ÷ EPS = P/E 25.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN)?
The dividend yield of PROTEAN EGOV TECHNOLOGIES LTD is 1.6% (payout 40.5%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN)?
The net margin of PROTEAN EGOV TECHNOLOGIES LTD is 10.1% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN)?
The return on equity (ROE) of PROTEAN EGOV TECHNOLOGIES LTD is 9.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN)?
On an EBIT basis the return on assets of PROTEAN EGOV TECHNOLOGIES LTD is 6.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN)?
The operating margin of PROTEAN EGOV TECHNOLOGIES LTD is 7.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN)?
Revenue at PROTEAN EGOV TECHNOLOGIES LTD is growing +38.4% versus a year earlier (3y avg +10.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN)?
Earnings per share at PROTEAN EGOV TECHNOLOGIES LTD are growing +49.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does PROTEAN EGOV TECHNOLOGIES LTD (PROTEAN) hold?
PROTEAN EGOV TECHNOLOGIES LTD holds more cash than debt, ₹990M net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch PROTEAN EGOV TECHNOLOGIES LTD in the live analysis

One click puts PROTEAN EGOV TECHNOLOGIES LTD on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.